Champions Oncology Inc (CSBR) — Cash Flow Reinvestment Rate

Latest as of July 2025: 0.15x

Champions Oncology Inc (CSBR) has a Cash Flow Reinvestment Rate of 0.15x as of July 2025, reinvesting $92.00K (capex $46.00K plus investments $-46.00K) from operating cash flow of $600.00K. Check Champions Oncology Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.15x
(Capex + Investments) / Operating CF

Total Reinvested

$92.00K
Capex + Investments

Operating Cash Flow

$600.00K
USD

Capital Expenditures

$46.00K
USD

Champions Oncology Inc Cash Flow Reinvestment Rate (1997–2025)

Historical reinvestment intensity for Champions Oncology Inc across 10 annual periods. Explore how well can Champions Oncology Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Champions Oncology Inc (1997–2025)

Year-by-year capital reinvestment analysis for Champions Oncology Inc. For live market cap and broader valuation context, see Champions Oncology Inc stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.11x $778.00K $7.39 Million $389.00K ▼ -92.7%
2023 1.45x $5.74 Million $3.96 Million $2.87 Million ▲ +97.9%
2022 0.73x $4.77 Million $6.50 Million $2.38 Million ▼ -52.0%
2020 1.53x $4.44 Million $2.90 Million $2.22 Million ▲ +70.6%
2019 0.90x $1.67 Million $1.86 Million $834.00K
2008 0.00x $0.00 $792.40K $0.00 ▼ -100.0%
2001 0.23x $33.72K $144.68K $33.72K ▲ +156.4%
1999 0.09x $10.00K $110.00K $10.00K ▲ +90.9%
1998 0.05x $20.00K $420.00K $20.00K ▼ -47.6%
1997 0.09x $10.00K $110.00K $10.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow